Skip to main content
Equibles

Ludovic Brellier

Avantor, Inc. (AVTR)

Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.

About Ludovic Brellier

Avantor, Inc. reported in an 8-K filed April 23, 2026 that Ludovic Brellier was appointed Executive Vice President, Bioscience and Medtech Products and Chief Transformation Officer, effective May 1, 2026.

“On April 23, 2026, the Company issued a press release announcing the hiring of Ludovic Brellier to serve as the Company's Executive Vice President, Bioscience and Medtech Products and Chief Transformation Officer effective May 1, 2026.”
Avantor, Inc. Form 8-K, filed April 23, 2026 · Read the filing

Summary generated from SEC filings and earnings-call records held by Equibles.

Affiliation history

Recorded current and former roles; source labels appear when available.

Company network

Recorded roles and call appearances connecting this person to public companies.

Leadership on record at Avantor, Inc.

Other people whose current roles at this company are on record from its filings.

Recent activity

Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.